|
Market Closed -
NYSE
16:00:02 2026-10-21 EDT
|
5-day change | 1st Jan Change | ||
| 257.46 USD | -0.03% |
|
+3.92% | +25.28% |
| 10-21 | Cencora to buy American Oncology Network in $2.4 billion deal | RE |
| 10-21 | Cencora to acquire American Oncology Network in $2.4 billion deal | RE |
| Market Cap | 59.64B 53.14B 49.2B 44.53B 83.89B 5,628B 84.88B 590B 231B 2,958B 224B 219B 9,426B | P/E 2027 * |
25.2x | P/E 2028 * | 22.3x |
|---|---|---|---|---|---|
| Enterprise Value | 61.51B 54.81B 50.75B 45.93B 86.53B 5,805B 87.55B 608B 239B 3,051B 231B 226B 9,723B | EV / Sales 2027 * |
0.23x | EV / Sales 2028 * | 0.21x |
| Free-Float |
85.66% | Yield 2027 * |
0.81% | Yield 2028 * | 0.83% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| CAH | Delayed | |
CBOE
| CAH | Real-time | |
|
London S.E.
| 0HTG | Delayed | |
|
Tradegate
| CLH | Real-time | |
|
Deutsche Boerse AG
| CLH | Delayed | |
|
Boerse Muenchen
| CLH | Real-time | |
|
Mexican S.E.
| CAH * | End-of-day quote | |
|
Xetra
| CLH | Delayed | |
|
Börse Stuttgart
| CLH | Delayed | |
|
Berne S.E.
| CLH | End-of-day quote | |
|
Borsa Italiana
| 1CAH | End-of-day quote | |
|
Wiener Boerse
| CAHE | End-of-day quote |
Last Transcript: Cardinal Health, Inc.
| 1 day | -0.03% | ||
| 1 week | +3.92% | ||
| Current month | +15.71% | ||
| 1 month | +14.05% | ||
| 3 months | +13.37% | ||
| 6 months | +25.64% | ||
| Current year | +25.28% |
| 1 week | 249.54 |  | 259.09 |
| 1 month | 216.7 | | 259.09 |
| Current year | 180.45 | | 259.09 |
| 1 year | 158.7 | | 259.09 |
| 3 years | 90.19 | | 259.09 |
| 5 years | 45.85 | | 259.09 |
| 10 years | 39.05 | | 259.09 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jason Hollar
CEO | Chief Executive Officer | 53 | 2022-08-31 |
Aaron Alt
DFI | Director of Finance/CFO | 55 | 2023-02-09 |
Ben Brinker
COO | Chief Operating Officer | - | 2022-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 2026-03-19 | |
Nancy Killefer
BRD | Director/Board Member | 71 | 2015-09-13 |
Akhil Johri
BRD | Director/Board Member | 64 | 2018-02-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/19/26 | Sell | Chief Executive Officer | -44,529 | 0.0190% | ||
| 8/19/26 | Sell | Controller/Auditor | -2,302 | 0.0010% | ||
| 8/18/26 | Sell | Executive/Senior Manager | -7,354 | 0.0031% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.03% | +3.92% | +62.25% | +178.70% | 59.64B | |
| -1.01% | +5.13% | +58.93% | +117.36% | 1,144B | |
| -0.61% | +1.52% | +34.34% | +68.48% | 625B | |
| -1.48% | +0.47% | +23.08% | +94.76% | 511B | |
| +0.54% | +5.69% | +39.60% | +64.02% | 377B | |
| +1.07% | +1.70% | +71.06% | +45.98% | 366B | |
| +0.30% | +3.44% | +21.35% | +49.62% | 291B | |
| -0.03% | +6.04% | +0.40% | +20.94% | 262B | |
| -0.14% | +2.87% | +45.56% | +57.22% | 237B | |
| -1.88% | +0.02% | +23.77% | +97.39% | 194B | |
| Average | -0.03% | +5.44% | +38.03% | +79.45% | 406.76B | |
| Weighted average by Cap. | +0.33% | +4.92% | +41.08% | +81.02% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 266B 237B 219B 198B 374B 25,080B 378B 2,629B 1,032B 13,183B 997B 976B 42,008B | 282B 251B 233B 210B 396B 26,598B 401B 2,788B 1,094B 13,981B 1,057B 1,035B 44,550B |
| Net income | 2.32B 2.07B 1.92B 1.73B 3.27B 219B 3.31B 22.98B 9.02B 115B 8.72B 8.53B 367B | 2.61B 2.33B 2.15B 1.95B 3.67B 246B 3.72B 25.82B 10.13B 129B 9.79B 9.59B 413B |
| Net Debt | 1.87B 1.67B 1.55B 1.4B 2.64B 177B 2.67B 18.54B 7.28B 92.99B 7.03B 6.89B 296B | 370M 330M 305M 276M 520M 34.91B 527M 3.66B 1.44B 18.35B 1.39B 1.36B 58.48B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-21 | US$257.46 | -0.03% | 1,586,043 |
| 26-10-20 | US$257.55 | +1.94% | 1,909,495 |
| 26-10-19 | US$252.65 | -0.55% | 3,781,726 |
| 26-10-16 | US$254.06 | +0.14% | 1,336,562 |
| 26-10-15 | US$253.71 | +2.41% | 2,055,478 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CAH Stock
Select your edition
All financial news and data tailored to specific country editions
